Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200549816> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4200549816 endingPage "48" @default.
- W4200549816 startingPage "41" @default.
- W4200549816 abstract "The prevalence of attention deficit hyperactivity disorder (ADHD), a developmental neuropsychiatric disorder, is high among children and adolescents. The pathogenesis of ADHD is mediated with genetic, biological, and environmental factors. Most therapeutic drugs for ADHD have so far targeted biological causes, primarily by regulating catecholaminergic neurotransmitters. However, ADHD drugs that are clinically treated have various problems in their addictiveness and drug stability; thus, it is recommended that efficacy and safety should be secured through simultaneous prescription of multiple drugs rather than a single drug treatment. Accordingly, it is necessary to develop drugs that newly target pathogenic mechanisms of ADHD. In this study, we attempt to confirm the possibility of developing new drugs by reviewing dopamine-related developmental mechanisms of neurons and their correlation with ADHD. Histone deacetylase inhibitors (HDACi) can regulate the concentration of intracellular dopamine in neurons by expressing vesicular monoamine transporter 2 and inducing the exocytosis of neurotransmitters to the synaptic cleft, thereby promoting the development of neurons and signal transmission. This cellular modulation of HDACi is expected to treat ADHD by regulating endogenous catecholamines such as dopamine. Although studies are still in the preclinical stage, HDAC inhibitors clearly have potential as a therapeutic agent with low addictiveness and high efficacy for ADHD treatment." @default.
- W4200549816 created "2021-12-31" @default.
- W4200549816 creator A5000379868 @default.
- W4200549816 creator A5020518655 @default.
- W4200549816 creator A5022059986 @default.
- W4200549816 creator A5060574958 @default.
- W4200549816 creator A5067615939 @default.
- W4200549816 creator A5086057697 @default.
- W4200549816 date "2021-12-31" @default.
- W4200549816 modified "2023-10-16" @default.
- W4200549816 title "Targeting Catecholamines to Develop New Drugs for Attention Deficit Hyperactivity Disorder" @default.
- W4200549816 doi "https://doi.org/10.22730/jmls.2021.18.3.41" @default.
- W4200549816 hasPublicationYear "2021" @default.
- W4200549816 type Work @default.
- W4200549816 citedByCount "0" @default.
- W4200549816 crossrefType "journal-article" @default.
- W4200549816 hasAuthorship W4200549816A5000379868 @default.
- W4200549816 hasAuthorship W4200549816A5020518655 @default.
- W4200549816 hasAuthorship W4200549816A5022059986 @default.
- W4200549816 hasAuthorship W4200549816A5060574958 @default.
- W4200549816 hasAuthorship W4200549816A5067615939 @default.
- W4200549816 hasAuthorship W4200549816A5086057697 @default.
- W4200549816 hasBestOaLocation W42005498161 @default.
- W4200549816 hasConcept C104317684 @default.
- W4200549816 hasConcept C118552586 @default.
- W4200549816 hasConcept C126322002 @default.
- W4200549816 hasConcept C15744967 @default.
- W4200549816 hasConcept C169760540 @default.
- W4200549816 hasConcept C170493617 @default.
- W4200549816 hasConcept C187714386 @default.
- W4200549816 hasConcept C2775864247 @default.
- W4200549816 hasConcept C2776291748 @default.
- W4200549816 hasConcept C2777112843 @default.
- W4200549816 hasConcept C2778305200 @default.
- W4200549816 hasConcept C2780035454 @default.
- W4200549816 hasConcept C2780557958 @default.
- W4200549816 hasConcept C2780783007 @default.
- W4200549816 hasConcept C42251903 @default.
- W4200549816 hasConcept C513476851 @default.
- W4200549816 hasConcept C55493867 @default.
- W4200549816 hasConcept C64927066 @default.
- W4200549816 hasConcept C71924100 @default.
- W4200549816 hasConcept C86803240 @default.
- W4200549816 hasConcept C98274493 @default.
- W4200549816 hasConceptScore W4200549816C104317684 @default.
- W4200549816 hasConceptScore W4200549816C118552586 @default.
- W4200549816 hasConceptScore W4200549816C126322002 @default.
- W4200549816 hasConceptScore W4200549816C15744967 @default.
- W4200549816 hasConceptScore W4200549816C169760540 @default.
- W4200549816 hasConceptScore W4200549816C170493617 @default.
- W4200549816 hasConceptScore W4200549816C187714386 @default.
- W4200549816 hasConceptScore W4200549816C2775864247 @default.
- W4200549816 hasConceptScore W4200549816C2776291748 @default.
- W4200549816 hasConceptScore W4200549816C2777112843 @default.
- W4200549816 hasConceptScore W4200549816C2778305200 @default.
- W4200549816 hasConceptScore W4200549816C2780035454 @default.
- W4200549816 hasConceptScore W4200549816C2780557958 @default.
- W4200549816 hasConceptScore W4200549816C2780783007 @default.
- W4200549816 hasConceptScore W4200549816C42251903 @default.
- W4200549816 hasConceptScore W4200549816C513476851 @default.
- W4200549816 hasConceptScore W4200549816C55493867 @default.
- W4200549816 hasConceptScore W4200549816C64927066 @default.
- W4200549816 hasConceptScore W4200549816C71924100 @default.
- W4200549816 hasConceptScore W4200549816C86803240 @default.
- W4200549816 hasConceptScore W4200549816C98274493 @default.
- W4200549816 hasIssue "3" @default.
- W4200549816 hasLocation W42005498161 @default.
- W4200549816 hasOpenAccess W4200549816 @default.
- W4200549816 hasPrimaryLocation W42005498161 @default.
- W4200549816 hasRelatedWork W1990060094 @default.
- W4200549816 hasRelatedWork W2001782638 @default.
- W4200549816 hasRelatedWork W2012847828 @default.
- W4200549816 hasRelatedWork W2043552268 @default.
- W4200549816 hasRelatedWork W2063046723 @default.
- W4200549816 hasRelatedWork W2128432842 @default.
- W4200549816 hasRelatedWork W2412315755 @default.
- W4200549816 hasRelatedWork W3082794202 @default.
- W4200549816 hasRelatedWork W3176074508 @default.
- W4200549816 hasRelatedWork W4200549816 @default.
- W4200549816 hasVolume "18" @default.
- W4200549816 isParatext "false" @default.
- W4200549816 isRetracted "false" @default.
- W4200549816 workType "article" @default.